Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of $0.06, $0.23 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $93.97 million versus the consensus estimate of $60.48 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.